Company news

LTR Pharma Limited news in 2025

LTR Pharma Limited's news releases, calls and decks from 2025, newest first.

View company

TGA Provides Regulatory Clearance for SPONTAN Phase II

December 9, 2025

Ethics Approval Received for SPONTAN Phase II Clinical Study

December 2, 2025

LTR increases LevOmega stake to 43% with $1m investment

October 5, 2025

LTR Pharma secures 33% ownership in LevOmega Pty Ltd

September 21, 2025

FY25 Results Announcement

August 28, 2025

Appendix 4E and Annual Report to Shareholders

August 28, 2025

SPONTAN Case Series - Strong Post-Prostatectomy Results

August 24, 2025

18-Month Shelf Life Strengthens SPONTAN Commercialisation

August 21, 2025

SPONTAN 5x Faster Onset Validated in EU Journal

August 19, 2025

LTP Completes Extractables Study Milestone for SPONTAN

June 29, 2025

Urological Expert Appointed to LTR Scientific Advisory Board

May 20, 2025

SPONTAN Expands Patient Access via National Pharmacy Network

May 19, 2025

LTR Signs Collaborative Agreement to Develop OMD Nasal Spray

May 7, 2025

Investor Presentation

March 26, 2025

Commercial Update and Regulatory Progress

March 25, 2025

LTR Pharma to Showcase SPONTAN Data at Urology Conference

February 27, 2025

LTR Signs Symbion National Pharmacy Distribution Agreement

January 21, 2025

Decks in 2025